Sat.Mar 06, 2021 - Fri.Mar 12, 2021

Crucial data on AstraZeneca's vaccine are coming. Here's what we may learn.

Bio Pharma Dive

Results from previous trials have raised questions about the vaccine and how well it works. Data from a large U.S. study could help clear up the confusion

Trials 251

America’s healthcare costs are in deep crisis

World of DTC Marketing

SUMMARY: The media loves to blame pharma companies for high healthcare costs, but unless we start to invest in healthy lifestyles, we’re headed for a healthcare crisis the likes of which we have never experienced.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

EU probes low platelet safety issue with COVID-19 shots

Pharma Phorum

EU regulators are reviewing reports of low blood platelets in patients who received any of the three approved COVID-19 vaccines from Pfizer/BioNTech, AstraZeneca and Moderna.

Filler 114

VirTrial and uMotif Partner to Further Expand Decentralized Clinical Trial Capabilities

VirTrial

Scottsdale, AZ – (March 9, 2021) – VirTrial , the leading provider of telemedicine technology, and uMotif , the patient-centric data capture platform provider, are joining forces to combine their Decentralized Clinical Trial (DCT) technologies in one seamlessly integrated solution.

How Rocket Pharma quietly became one of gene therapy's high flyers

Bio Pharma Dive

An unconventional strategy is behind the rise of Rocket, a New Jersey biotech whose executives boldly talk of turning into the "Genentech of gene therapy "

Loneliness Linked to Serious Health Conditions

World of DTC Marketing

Drugs 165

New Drug Approval Could Be on Horizon for Alzheimer’s after 17-Year Drought

BioSpace

A drug to halt the progression of Alzheimer’s disease will likely be approved within the next three years, and Alzheon’s ALZ-801 might be the leading candidate

Drugs 113

More Trending

Vertex begins human testing for diabetes cell therapy

Bio Pharma Dive

While Vertex is confident in the therapy, which came via the $1 billion acquisition of Semma Therapeutics, it will still be a few years before the company has a good read on its effects in Type 1 diabetes patients

240
240

Is it time for DTC marketers to use a CMP?

World of DTC Marketing

SUMMARY: In its simplest form, a creative management platform , or CMP, is a cloud-based software that allows marketing teams to create, distribute, and measure the performance of digital advertising.

How to Use Public Relations to Improve your Recruitment Strategy

BioSpace

Using public relations strategies creates more opportunities for passive candidates to be exposed to your organization – and learn about your open roles

99

Shutting the nano-gate

Scienmag

Merck gives an early peek at COVID-19 drug results

Bio Pharma Dive

Initial results from a mid-stage study indicate the antiviral drug, molnupiravir, is safe. But whether it's hitting the study's main goal remains unclear

Drugs 238

Why hasn’t pharma embraced email marketing?

World of DTC Marketing

SUMMARY : DTC marketers are spending tens of millions of dollars on programmatic ads that are full of fraud and have low click-through rates but they have yet to embrace email marketing which has an average click-through rate of 3.43%.

Austrian safety officials suspend batch of AZ vaccines after death

Pharma Phorum

Austrian health officials have withdrawn a batch of Oxford University/AstraZeneca’s COVID-19 vaccine after two cases of severe coagulation, one of which was fatal. Both patients were treated from the same batch, codenamed ABV 5300, in the district of Zwettl.

New COVID-19 vaccine candidate leveraging nanotechnology is ‘promising’

BioPharma Reporter

Researchers from Cleveland Clinic's Global Center for Pathogen Research & Human Health, who have developed the nanotechnology based vaccine, say it has shown strong efficacy in preclinical disease models. Bio Developments

The top drugs that could be impacted by an obscure provision in the pandemic relief law

Bio Pharma Dive

Elimination of the so-called penny rule in Medicaid could force drugmakers to pay larger rebates on a number of top medicines, including some HIV, diabetes and anti-inflammatory drugs

Telehealth concerns rise

World of DTC Marketing

SUMMARY: Once again, the “hype” may be bigger than the reality around telehealth. First, people aren’t always completely honest with their doctors.

First AI system for contactless monitoring of heart rhythm using smart speakers

Scienmag

Credit: Mark Stone/University of Washington Smart speakers, such as Amazon Echo and Google Home, have proven adept at monitoring certain health care issues at home.

Gilead’s HIV therapy Biktarvy demonstrates long-term sustained efficacy

Pharma Times

Data from two Phase III studies demonstrated durable viral suppression in HIV-1 patients

97

Vir breaks through with study success for COVID-19 antibody

Bio Pharma Dive

A data monitoring board said a study testing Vir's drug should be stopped early because of an overwhelming benefit from treatment

Cambridge Sleep Sciences’ device is trialled in Parkinson’s

Pharma Phorum

Sleep disturbances are a common feature for people with Parkinson’s disease, and a device developed to help people with insomnia is now being trialled to see if it can improve their sleep quality. .

A better way to measure acceleration

Scienmag

NIST researchers rely on a light touch. Credit: F. Zhou/NIST You’re going at the speed limit down a two-lane road when a car barrels out of a driveway on your right.

Pfizer COVID-19 vaccine appears effective against Brazil variant

BioPharma Reporter

A laboratory study published in the New England Journal of Medicine shows the Pfizer/BioNTech COVID-19 vaccine was able to neutralize the emerging Brazil coronavirus strain. Bio Developments

FDA sets meeting to review 6 speedy cancer drug approvals as evaluation widens

Bio Pharma Dive

At a public hearing in April, the agency will ask a panel of experts whether three immunotherapies should remain on the market for certain cancer types, the latest step in an industrywide review

AI drug discovery firm Valence joins Parkinson’s disease push

Pharma Phorum

Canada’s Valence Discovery has joined a University of Montreal-led project to try to find new drugs to treat the involuntary movement complications that can accompany treatments for Parkinson’s disease. .

Immuno-PET can give physicians early insight into tumor response to targeted therapy

Scienmag

Credit: Image created by Patricia Pereira, PhD, Research Associate at Memorial Sloan Kettering Cancer Center Reston, VA–Immuno-positron emission tomography (PET) imaging can provide early insight into a tumor’s response to targeted therapy, allowing physicians to select the most effective treatment for patients who have cancer.

Jennifer Doudna’s Second Act: COVID-19 and Beyond

BioSpace

Doudna, the subject of a new book by Walter Isaacson titled “The Code Breaker: Jennifer Doudna, Gene Editing, and the Future of the Human Race,” has kept busy

Spurred by FDA review, Roche pulls Tecentriq for bladder cancer use

Bio Pharma Dive

Four years after negative study results, the pharma withdrew the indication as the FDA's "industry-wide evaluation" of accelerated approvals progresses

193
193

Patient involvement in trial design: looking to the future

Pharma Phorum

COVID-19 has transformed the way we think about patient participation in trial design – but there are still many barriers to overcome in improving engagement. Speakers at the NIHR’s recent virtual event for the pharma industry discussed best practices for bringing patient insights into research.

Natural “brake” against malignant neuroblastoma

Scienmag

Credit: Photo: Sabine Taschner-Mandl, PhD, and Tamara Weiss, PhD Copyright: St. Anna Children’s Cancer Research Institute Image: Immunofluorescence image of Schwann cells (magenta) and neuroblastoma cells (green) Copyright: Weiss T, Taschner-Mandl S et al.,…

New real-world evidence for Pfizer/BioNTech COVID-19 vaccine

Pharma Times

Evidence demonstrates lower incidence rates of COVID-19 in fully vaccinated individuals

Lilly builds case for COVID-19 drug cocktail with new data

Bio Pharma Dive

A low-dose combination of Lilly antibodies for COVID-19 reduced deaths and hospitalizations in a Phase 3 trial, a finding that could boost its use

New era of genomic medicine begins as UK approves Lilly’s Retsevmo

Pharma Phorum

The UK regulator has authorised Eli Lilly’s targeted cancer drug Retsevmo for tumours with RET fusion positive lung cancers and thyroid cancers, which the company said could herald a new era of genomic medicine for the NHS.

Award-winning professor writes forgotten women into tech-history

Scienmag

COVID-19 Vaccine News: Moderna Variant Vaccine Begins Human Testing, AZ Put on Hold in Denmark

BioSpace

Patients in a Phase II trial have begun receiving Moderna’s vaccine against the SARS-CoV-2 variant first identified in South Africa, the company announced

A closer look at the manufacturing scale-up hastening the coronavirus vaccine push

Bio Pharma Dive

The U.S. is now averaging more than 2 million doses given each day, a pace that will help President Joe Biden meet his target of 100 million shots in 100 days well ahead of schedule

J&J manufacturing delays hit US vaccine rollout

Pharma Phorum

The rollout of the US COVID-19 vaccination programme slowed up this week because manufacturing delays mean no new doses of the recently approved Johnson & Johnson vaccine are available. The White House said on Tuesday that the government will distribute around 18.5